Avicena LLC DBA Ventric Health

Ventric Health manufactures the Vivio® System, an FDA-cleared Class II medical device for non-invasive heart failure diagnosis in primary care settings. The Vivio System uniquely measures left ventricular end-diastolic pressure (LVEDP)—the clinical hallmark of heart failure—using a portable, point-of-care approach combining brachial cuff and ECG technology. The system delivers results in under five minutes and integrates the Kansas City Cardiomyopathy Questionnaire 12 (KCCQ-12) to assess patient symptoms and disease burden. Approximately 70% of patients identified with elevated LVEDP exhibit Stage C heart failure symptoms, while 30% present Stage B findings. The Vivio System demonstrates superior specificity and sensitivity compared to traditional clinical indicators, enabling clinicians to identify at-risk patients earlier and initiate guideline-directed medical therapy more promptly. Target markets include primary care physicians, cardiologists, Medicare ACOs, healthcare systems, and Medicare Advantage plans. The company has established partnerships with leading health systems including Agilon Health, AltaMed, Desert Oasis Healthcare, Heritage Victor Valley Medical Group, and Regal Medical Group. Ventric Health is based in Pasadena, California, and operates through clinical validation studies published in peer-reviewed journals including JACC: Advances and the Journal of the American Heart Association.